KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Return on Equity (2017)

Astrazeneca has reported Return on Equity over the past 2 years, most recently at 0.0% for Q4 2018.

  • For Q4 2018, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2018 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Equity for Q4 2018 was 0.0% at Astrazeneca, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q4 2017 and troughed at 0.0% in Q4 2018.